Alan Pang (pictured) joins Intelligent Fingerprinting from drug and alcohol testing provider Alere Toxicology, where he was head of technical manufacturing and assay development.
His appointment is part of the continued expansion of Intelligent Fingerprinting’s R&D and manufacturing facilities, where he will play a key role in supporting the introduction of the company’s fingerprint-based Drug Screening System later this summer.
Says Pang: “Throughout my career I’ve tracked all the key innovations in drug screening technology, and it has become clear that fingerprint-based testing – which works by analysing the sweat from a fingerprint sample – has the potential to disrupt the industry in a major way.
“The fact that the technology is portable, rapid, non-invasive and easy-to-use makes it particularly attractive across a range of important market sectors, so I was obviously keen to get involved.”
Dr Jerry Walker, Intelligent Fingerprinting’s chief, adds: “Alan Pang’s appointment is a pivotal addition to the Intelligent Fingerprinting R&D team as we move towards commercialisation. He brings in-depth experience of the drug screening challenges facing organisations across our target sectors, as well as a real understanding of how our portable Intelligent Fingerprinting system can play an important role in supporting both current and future drug screening requirements.”
In April, the company also appointed a director of quality to head up quality assurance and regulatory affairs activities.
